Response Biomedical Seeks to Raise $9.5M | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical has filed a prospectus to sell 73,333,333 units at a price of C$.15 per unit for gross proceeds of around C$11 million (US$9.5 million).

Each unit will consist of one common share and one-half of one common share purchase warrant. Each whole warrant will enable the holder to purchase one additional common share at a price of C$.25 for a period of 24 months from the closing date of the offering, which is expected on or around May 21, said Response Biomedical.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.